IBDEI11O ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17735,1,3,0)
 ;;=3^Legionella pneumonia/Legionnnaire's
 ;;^UTILITY(U,$J,358.3,17735,1,4,0)
 ;;=4^A48.1
 ;;^UTILITY(U,$J,358.3,17735,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,17736,0)
 ;;=D72.829^^76^858^141
 ;;^UTILITY(U,$J,358.3,17736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17736,1,3,0)
 ;;=3^Leukocytosis
 ;;^UTILITY(U,$J,358.3,17736,1,4,0)
 ;;=4^D72.829
 ;;^UTILITY(U,$J,358.3,17736,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,17737,0)
 ;;=B85.2^^76^858^145
 ;;^UTILITY(U,$J,358.3,17737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17737,1,3,0)
 ;;=3^Lice,Unspec
 ;;^UTILITY(U,$J,358.3,17737,1,4,0)
 ;;=4^B85.2
 ;;^UTILITY(U,$J,358.3,17737,2)
 ;;=^5000806
 ;;^UTILITY(U,$J,358.3,17738,0)
 ;;=A69.20^^76^858^147
 ;;^UTILITY(U,$J,358.3,17738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17738,1,3,0)
 ;;=3^Lyme disease, unspecified
 ;;^UTILITY(U,$J,358.3,17738,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,17738,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,17739,0)
 ;;=R59.1^^76^858^148
 ;;^UTILITY(U,$J,358.3,17739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17739,1,3,0)
 ;;=3^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,17739,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,17739,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,17740,0)
 ;;=R53.81^^76^858^149
 ;;^UTILITY(U,$J,358.3,17740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17740,1,3,0)
 ;;=3^Malaise NEC
 ;;^UTILITY(U,$J,358.3,17740,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,17740,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,17741,0)
 ;;=R53.83^^76^858^85
 ;;^UTILITY(U,$J,358.3,17741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17741,1,3,0)
 ;;=3^Fatigue NEC
 ;;^UTILITY(U,$J,358.3,17741,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,17741,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,17742,0)
 ;;=B54.^^76^858^150
 ;;^UTILITY(U,$J,358.3,17742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17742,1,3,0)
 ;;=3^Malaria,Unspec
 ;;^UTILITY(U,$J,358.3,17742,1,4,0)
 ;;=4^B54.
 ;;^UTILITY(U,$J,358.3,17742,2)
 ;;=^5000703
 ;;^UTILITY(U,$J,358.3,17743,0)
 ;;=G03.0^^76^858^152
 ;;^UTILITY(U,$J,358.3,17743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17743,1,3,0)
 ;;=3^Meningitis,Aseptic
 ;;^UTILITY(U,$J,358.3,17743,1,4,0)
 ;;=4^G03.0
 ;;^UTILITY(U,$J,358.3,17743,2)
 ;;=^268379
 ;;^UTILITY(U,$J,358.3,17744,0)
 ;;=G00.9^^76^858^153
 ;;^UTILITY(U,$J,358.3,17744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17744,1,3,0)
 ;;=3^Meningitis,Bacterial
 ;;^UTILITY(U,$J,358.3,17744,1,4,0)
 ;;=4^G00.9
 ;;^UTILITY(U,$J,358.3,17744,2)
 ;;=^5003724
 ;;^UTILITY(U,$J,358.3,17745,0)
 ;;=G03.9^^76^858^151
 ;;^UTILITY(U,$J,358.3,17745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17745,1,3,0)
 ;;=3^Meningitis NOS
 ;;^UTILITY(U,$J,358.3,17745,1,4,0)
 ;;=4^G03.9
 ;;^UTILITY(U,$J,358.3,17745,2)
 ;;=^5003729
 ;;^UTILITY(U,$J,358.3,17746,0)
 ;;=B27.90^^76^858^155
 ;;^UTILITY(U,$J,358.3,17746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17746,1,3,0)
 ;;=3^Mononucleosis
 ;;^UTILITY(U,$J,358.3,17746,1,4,0)
 ;;=4^B27.90
 ;;^UTILITY(U,$J,358.3,17746,2)
 ;;=^5000578
 ;;^UTILITY(U,$J,358.3,17747,0)
 ;;=A31.0^^76^858^157
 ;;^UTILITY(U,$J,358.3,17747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17747,1,3,0)
 ;;=3^Mycobacteria, Atypical, Pulmonary
 ;;^UTILITY(U,$J,358.3,17747,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,17747,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,17748,0)
 ;;=A15.9^^76^858^159
 ;;^UTILITY(U,$J,358.3,17748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17748,1,3,0)
 ;;=3^Mycobacterium, Tuberculosis active disease
 ;;^UTILITY(U,$J,358.3,17748,1,4,0)
 ;;=4^A15.9
 ;;^UTILITY(U,$J,358.3,17748,2)
 ;;=^5000066
